Clinical Trial Update: High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating high- or standard-intensity radiation therapy after gemcitabine and nab-paclitaxel in unresectable pancreatic cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Abraxane (paclitaxel protein-bound particles for injectable suspension) (paclitaxel protein-bound particles for injectable suspension)
• Gemzar (gemcitabine) (gemcitabine)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-03-22